Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reproducibility in Nerve Block Duration
NCT03310047Phase 1Completed
- Sponsor
- Nordsjællands Hospital
- Start
- Oct 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of Lidocaine Hydrochloride Injection, without epinephrine (2 arms), sponsored by Nordsjællands Hospital. Primary endpoint: Duration of insensitivity towards cold at 10 hours. Started Oct 2017; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
Beyond the preview
Go deeper on NCT03310047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03310047.